Long‐term blood pressure variability (BPV) and plasma neurofilament light (pNfL) have been identified as potential biomarkers for Alzheimer's disease (AD) and cerebral small vessel disease (CSVD). This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.